Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | PBRM1 | Q86U86 | 1/20 | 1.00 |
| ▸ | ATM | Q13315 | 1/20 | 0.71 |
| ▸ | TDP1 | Q9NUW8 | 1/20 | 0.71 |
| ▸ | L3MBTL1 | Q9Y468 | 1/20 | 0.71 |
| ▸ | NPC1 | O15118 | 1/20 | 0.65 |
| ▸ | MITF | O75030 | 1/20 | 0.65 |
| ▸ | LMNA | P02545 | 1/20 | 0.65 |
| ▸ | POLB | P06746 | 1/20 | 0.65 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.61 |
| ▸ | CA1 | P00915 | 2/20 | 0.60 |
| ▸ | CA2 | P00918 | 2/20 | 0.60 |
| ▸ | CA9 | Q16790 | 1/20 | 0.60 |
| ▸ | MEN1 | O00255 | 1/20 | 0.52 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.52 |
| ▸ | SRD5A2 | P31213 | 1/20 | 0.52 |
| ▸ | STS | P08842 | 1/20 | 0.51 |
| ▸ | MAPT | P10636 | 2/20 | 0.50 |
| ▸ | NOX1 | Q9Y5S8 | 1/20 | 0.50 |
| ▸ | PTGS1 | P23219 | 1/20 | 0.50 |
| ▸ | CXCR1 | P25024 | 1/20 | 0.50 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| Hydrochloric Acid SCHEMBL9646439 | 0.98 | PBRM1 (0.96) | PBRM1ATMTDP1L3MBTL1NPC1 | |
| Benzene SCHEMBL8764875 | 0.93 | PBRM1 (0.88) | PBRM1ATMTDP1L3MBTL1NPC1 | |
| SCHEMBL29492473 | 0.93 | PBRM1 (0.88) | PBRM1ATMTDP1L3MBTL1NPC1 | |
| SCHEMBL9097509 | 0.93 | PBRM1 (0.88) | PBRM1ATMTDP1L3MBTL1NPC1 | |
| SCHEMBL203373 | 0.93 | PBRM1 (0.88) | PBRM1ATMTDP1L3MBTL1NPC1 | |
| SCHEMBL29363032 | 0.93 | PBRM1 (0.87) | PBRM1ATMTDP1L3MBTL1NPC1 | |
| SCHEMBL9282073 | 0.93 | PBRM1 (0.87) | PBRM1ATMTDP1L3MBTL1NPC1 | |
| SCHEMBL125621 | 0.93 | PBRM1 (0.87) | PBRM1ATMTDP1L3MBTL1NPC1 | |
| Hydrochloric Acid SCHEMBL8643223 | 0.91 | PBRM1 (0.83) | PBRM1ATMTDP1L3MBTL1NPC1 | |
| SCHEMBL29492479 | 0.91 | PBRM1 (0.83) | PBRM1ATMTDP1L3MBTL1NPC1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 867 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-12440607-B2 | Multifunctional crosslinkers: compounds, compositions, and products thereof | BIOCOAT, INCORPORATED (US) | 2025-10-14 | — | — | US | claimed |
| CN-119464808-B | Soft magnetic composite material and preparation method thereof | 杭州新川新材料有限公司 | 2025-05-06 | — | — | CN | claimed |
| CN-119570164-A | High-weather-resistance spectrum plastic particle and preparation method thereof | 广德全诚新材料有限公司 | 2025-03-07 | — | — | CN | claimed |
| CN-119464808-A | Soft magnetic composite material and preparation method thereof | 杭州新川新材料有限公司 | 2025-02-18 | — | — | CN | claimed |
| CN-118119593-A | Multifunctional crosslinking agent: compounds, compositions and products thereof | 生物涂层有限公司 | 2024-05-31 | — | — | CN | claimed |
| EP-4370498-A1 | MULTIFUNCTIONAL CROSSLINKERS: COMPOUNDS, COMPOSITIONS, AND PRODUCTS THEREOF | Biocoat, Incorporated (US) | 2024-05-22 | — | — | EP | claimed |
| CN-116855225-B | UV-thermal dual-curing organic silica gel adhesive and preparation method thereof | 韦尔通科技股份有限公司 | 2024-04-16 | — | — | CN | claimed |
| CN-116855225-A | UV-thermal dual-curing organic silica gel adhesive and preparation method thereof | 韦尔通科技股份有限公司 | 2023-10-10 | — | — | CN | claimed |
| CN-116731375-A | Polymer surface modification method, obtained surface modified polymer and application thereof | 中国科学院赣江创新研究院 | 2023-09-12 | — | — | CN | claimed |
| US-20230027324-A1 | Multifunctional Crosslinkers: Compounds, Compositions, And Products Thereof | WELLS FARGO BANK, NATIONAL ASSOCIATION, AS ADMINISTRATIVE AGENT | 2023-01-26 | — | — | US | claimed |
| EP-1819341-A2 | IL-12 MODULATORY COMPOUNDS | Synta Pharmaceuticals Corporation (US) | 2007-08-22 | — | — | EP | claimed |
| EP-1773768-A2 | PYRROLE DERIVATIVES AS PHARMACEUTICAL AGENTS | Exelixis, Inc. (US) | 2007-04-18 | — | — | EP | claimed |
| WO-2007034035-A1 | SULPHONAMIDE DERIVATIVES | BIOTIE THERAPIES CORPORATION (FI) | 2007-03-29 | — | — | WO | claimed |
| WO-2007031608-A1 | COLLAGEN RECEPTOR I-DOMAIN BINDING MODULATORS | BIOTIE THERAPIES CORPORATION (FI) | 2007-03-22 | — | — | WO | claimed |
| US-20060223996-A1 | IL-12 modulatory compounds | SYNTA PHARMACEUTICALS CORP. (US) | 2006-10-05 | — | — | US | claimed |
| WO-2006053227-A2 | IL-12 MODULATORY COMPOUNDS | SYNTA PHARMACEUTICALS CORP. (US) | 2006-05-18 | — | — | WO | claimed |
| WO-2006012642-A2 | PYRROLE DERIVATIVES AS PHARMACEUTICAL AGENTS | EXELIXIS, INC. (US) | 2006-02-02 | — | — | WO | claimed |
| US-6890626-B1 | Imide-benzoxazole polycondensate and process for producing the same | PI R&D CO., LTD. (JP) | 2005-05-10 | — | — | US | claimed |
| WO-2002028353-A2 | PHOSPHATE TRANSPORT INHIBITORS | SMITHKLINE BEECHAM CORPORATION (US) | 2002-04-11 | — | — | WO | claimed |
| US-5260388-A | Reacting aromatic diamine with tetracarboxylic anhydride in presence of aromatic dicarboxylic anhydride or monoamine, imidizing; low dielectric characteristics; electronics | MITSUI TOATSU CHEMICALS, INCORPORATED (JP) | 1993-11-09 | — | — | US | claimed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20060223996-A1 | IL-12 modulatory compounds | IL2, IL4, IFNG | PBRM1 3010/4885ATM 4046/4885TDP1 4729/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.